[go: up one dir, main page]

FI931031L - Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar - Google Patents

Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar Download PDF

Info

Publication number
FI931031L
FI931031L FI931031A FI931031A FI931031L FI 931031 L FI931031 L FI 931031L FI 931031 A FI931031 A FI 931031A FI 931031 A FI931031 A FI 931031A FI 931031 L FI931031 L FI 931031L
Authority
FI
Finland
Prior art keywords
mometasonfuroatmonohydrat
farmaceutiska
sammansaettningar
foerfarande foer
framstaellning och
Prior art date
Application number
FI931031A
Other languages
English (en)
Other versions
FI111078B (fi
FI931031A0 (fi
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI931031(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI931031L publication Critical patent/FI931031L/fi
Publication of FI931031A0 publication Critical patent/FI931031A0/fi
Application granted granted Critical
Publication of FI111078B publication Critical patent/FI111078B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI931031A 1990-09-10 1993-03-09 Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi FI111078B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
US58023990 1990-09-10
PCT/US1991/006249 WO1992004365A1 (en) 1990-09-10 1991-09-06 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US9106249 1991-09-06

Publications (3)

Publication Number Publication Date
FI931031L true FI931031L (fi) 1993-03-09
FI931031A0 FI931031A0 (fi) 1993-03-09
FI111078B FI111078B (fi) 2003-05-30

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931031A FI111078B (fi) 1990-09-10 1993-03-09 Menetelmä mometasonifuroaattimonohydraatin valmistamiseksi

Country Status (35)

Country Link
US (1) US6180781B1 (fi)
EP (1) EP0548114B1 (fi)
JP (1) JPH0725789B2 (fi)
KR (1) KR960013445B1 (fi)
CN (1) CN1030920C (fi)
AT (1) ATE113604T1 (fi)
AU (1) AU663471B2 (fi)
BG (1) BG60755B2 (fi)
CA (1) CA2091360C (fi)
CZ (1) CZ281318B6 (fi)
DE (2) DE19875032I2 (fi)
DK (1) DK0548114T5 (fi)
EE (1) EE02962B1 (fi)
ES (1) ES2065701T3 (fi)
FI (1) FI111078B (fi)
HK (1) HK185996A (fi)
HR (1) HRP920383B1 (fi)
HU (1) HU213401B (fi)
IE (1) IE67056B1 (fi)
IL (1) IL99437A (fi)
LU (1) LU90366I2 (fi)
MX (2) MX9203396A (fi)
MY (1) MY106644A (fi)
NL (1) NL980012I2 (fi)
NO (1) NO300548B1 (fi)
NZ (1) NZ239711A (fi)
OA (1) OA09772A (fi)
PH (1) PH30443A (fi)
PL (1) PL165803B1 (fi)
PT (1) PT98905B (fi)
SI (1) SI9111497A (fi)
TW (2) TW229208B (fi)
WO (1) WO1992004365A1 (fi)
YU (1) YU48666B (fi)
ZA (1) ZA917148B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113604T1 (de) * 1990-09-10 1994-11-15 Schering Corp Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
PE44995A1 (es) 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
EP1033991B1 (en) * 1997-10-09 2002-04-17 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
NZ515134A (en) 1999-05-04 2004-01-30 Strakan Ltd Androgen glycosides and androgenic activity thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20120015334A (ko) 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
ATE113604T1 (de) * 1990-09-10 1994-11-15 Schering Corp Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
HUT64361A (en) 1993-12-28
JPH05506667A (ja) 1993-09-30
DE19875032I2 (de) 2007-04-19
SI9111497A (sl) 1998-04-30
DK0548114T5 (da) 1995-01-30
CN1030920C (zh) 1996-02-07
ES2065701T3 (es) 1995-02-16
YU149791A (sh) 1994-01-20
NL980012I2 (nl) 2004-11-01
CZ38393A3 (en) 1994-01-19
IE913155A1 (en) 1992-03-11
CA2091360C (en) 1997-04-08
YU48666B (sh) 1999-06-15
AU663471B2 (en) 1995-10-12
JPH0725789B2 (ja) 1995-03-22
IL99437A0 (en) 1992-08-18
EP0548114B1 (en) 1994-11-02
IE67056B1 (en) 1996-02-21
FI111078B (fi) 2003-05-30
HK185996A (en) 1996-10-11
PT98905B (pt) 1998-08-31
DE69104991T2 (de) 1995-04-20
AU8497491A (en) 1992-03-30
NO300548B1 (no) 1997-06-16
HRP920383B1 (en) 2000-04-30
NO930693D0 (no) 1993-02-26
WO1992004365A1 (en) 1992-03-19
HU9300685D0 (en) 1993-06-28
EE02962B1 (et) 1997-02-17
PL165803B1 (pl) 1995-02-28
OA09772A (en) 1993-11-30
ZA917148B (en) 1992-08-26
ATE113604T1 (de) 1994-11-15
EP0548114A1 (en) 1993-06-30
LU90366I2 (fr) 1999-05-05
NO930693L (no) 1993-02-26
DE69104991D1 (de) 1994-12-08
CZ281318B6 (cs) 1996-08-14
IL99437A (en) 1995-05-29
MX9203396A (es) 1992-07-31
CA2091360A1 (en) 1992-03-11
HRP920383A2 (en) 1998-06-30
PT98905A (pt) 1992-09-30
PH30443A (en) 1997-05-09
US6180781B1 (en) 2001-01-30
KR960013445B1 (ko) 1996-10-05
CN1059911A (zh) 1992-04-01
TW229208B (fi) 1994-09-01
HU213401B (en) 1997-06-30
BG60755B2 (bg) 1996-02-29
FI931031A0 (fi) 1993-03-09
MY106644A (en) 1995-07-31
MX9100990A (es) 1992-05-04
TW272195B (fi) 1996-03-11
NZ239711A (en) 1992-09-25
NL980012I1 (nl) 1998-05-06

Similar Documents

Publication Publication Date Title
FI931031L (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
FI911499A0 (fi) Kapslat aromavgivningssystem och foerfarande foer dess framstaellning.
FI911498L (fi) Pressad tablett och foerfarande foer dess framstaellning.
FI912328L (fi) Peptidfoerening och dess framstaellning.
FI904261L (fi) Raomaterialbrikett foer mineralullstillverkning och foerfarande foer dess framstaellning.
FI933888L (fi) Aertproteinhydrolysat, foerfarande foer dess framstaellning och anvaendningdaerav
FI915120L (fi) Kardbar hydrofobisk polyolefinfiber och foerfarande foer dess framstaellning.
FI905268A7 (fi) Roerdel och foerfarande foer dess tillverkning.
FI913854L (fi) Sjaelvhaerdad kiselnitridkeramikkropp och foerfarande foer dess framstaellning.
FI910481L (fi) Belaeggningskniv och foerfarande foer dess faestande.
FI904124A0 (fi) Oligosackaridblandning och foerfarande foer dess framstaellning.
FI900804A7 (fi) Jaestpreparat och foerfarande foer dess framstaellning.
FI911683A0 (fi) Pressad laogkaloritablett och foerfarande foer dess framstaellning.
FI912506L (fi) Vattenstav foer kaernreaktorer och dess framstaellnings- och anvaendningsfoerfarande.
FI914501L (fi) Majonaesprodukt med laog fetthalt och foerfarande foer dess framstaellning.
FI912504L (fi) Kabelstyrningsanordning och foerfarande foer dess framstaellning.
FI923679L (fi) Ny b-fenylisoserinderivat, dess framstaellning och anvaendning
FI925833L (fi) Tricykliskt triazolderivat, dess framstaellning och dess anvaendning
FI912380A7 (fi) Taetningsmuff och dess anvaendning.
FI906192A7 (fi) Vaexelriktarbryggenhet och foerfarande foer dess anvaendning.
FI913972A0 (fi) Inuti avkyld rulle foer en straenggjutanordning och foerfarande foer dess framstaellning.
FI905402L (fi) Oligosackaridblandning och foerfarande foer dess efterbehandling.
FI912562A0 (fi) Flerskiktig metallplaotkonstruktion och foerfarande foer dess tillverkning.
FI923406A0 (fi) Matteringsmedel foer anvaendning med vattenloesligt polyuretan och foerfarande foer dess framstaellning.
FI904779A0 (fi) Ledningskoppling och foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20030010

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 219

Extension date: 20120219

MA Patent expired